---
title: "Biorepository and Processing services"
ocid: "ocds-h6vhtk-065523"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-065523"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-065523.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-065523.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "GENOMICS ENGLAND LIMITED"
published: "2026-02-23"
---

# Biorepository and Processing services

Buyer: GENOMICS ENGLAND LIMITED  
Current stage: Award  
OCID: ocds-h6vhtk-065523

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-065523)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-065523.json)

## Summary

The procurement process managed by Genomics England Limited, based in London, pertains to "Biorepository and Processing Services" in the healthcare industry category. The contract was awarded via a direct award method to UK BioCentre Limited, located in Milton Keynes. This procurement involves comprehensive management services for biological samples, including crucial processes like DNA and RNA extraction and storage. The contract period extends from 1st April 2026 to 31st March 2028, enabling possible expansions through a structured Change Control procedure. The award decision was completed on 23rd February 2026, with a standstill period ending on 4th March 2026.

This tender represents a significant business opportunity for firms specialising in life sciences, particularly those capable of handling large volumes of biological sample processing. Companies with robust laboratory workflows and capacity to develop project-specific solutions would find this contract advantageous for growth. Due to the technical nature and high standards of operations required, larger institutions with existing infrastructure for secure and controlled environments would be well-suited to compete in similar tenders within the domain of genomic services and biorepositories. The arrangement allows for future expansions via the Change Control procedure, providing further opportunities for businesses to enhance their service offerings.

## Notice

The services cover end-to-end management of biological samples, including receipt, verification and secure storage in controlled ultra-low-temperature environments. Samples are processed through a range of laboratory workflows that include DNA and RNA extraction, quality control testing, normalisation, and preparation for downstream sequencing all delivered on a per-sample basis, there is no fixed maximum number of samples. Additional activities include aliquoting, pooling, reformatting into required labware, and arranging shipments to designated laboratories. Project-specific workflows may be developed to meet bespoke requirements.

### Procurement Information

The delivery of services under a new contract with the existing supplier is proposed in accordance with Schedule 5, Paragraph 7 of the Procurement Act 2023, which enables a direct award where a change of supplier would result in incompatible goods or services and where such incompatibility would give rise to disproportionate technical difficulties in operation or maintenance. The remaining activity represents a continuation of established work already underway within the programme, and the new contractual arrangement does not introduce any additional or materially altered services. Transitioning to an alternative supplier at this stage would require substantial changes to embedded methodologies, operational processes and systems integration, resulting in significant incompatibilities with the established technical approach. Crucially, a change of supplier would also necessitate the transportation of a substantial volume of biological samples to a new provider. This introduces a material and unacceptable risk of contamination, loss, degradation or compromise of sample integrity, given the heightened handling requirements, increased logistical steps, and the sensitivity of the sample types involved. Such risks would directly threaten the comparability, consistency and scientific validity of programme outputs. Managing these transportation risks-alongside the need to migrate complex datasets, workflows and sample handling processes-would introduce disproportionate technical difficulties, as anticipated under Schedule 5, Paragraph 7, and would undermine the robustness of the study's established operational and analytical frameworks. Maintaining service delivery with the incumbent supplier therefore ensures continuity of technical methodologies, operational processes and quality controls, safeguarding the reliability and stability of the remaining programme work. In these circumstances, awarding a new contract to the existing supplier meets the criteria under Schedule 5, Paragraph 7, as a change in supplier would result in incompatible services and introduce unreasonable and disproportionate technical and logistical difficulties. The direct award is therefore the most appropriate, proportionate and compliant procurement route under the Procurement Act 2023.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/015976-2026 |
| Notice type | UK6 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 23 Feb 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 16 Feb 2026 |
| Contract period | 31 Mar 2026 - 31 Mar 2028 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £1,843,498 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Pending |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | GENOMICS ENGLAND LIMITED |
| Locality | LONDON |
| Post town | East London |
| Postcode | E14 5AB |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | UK BIOCENTRE |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85111810 - Blood analysis services

## Release History

- 23 Feb 2026 at 10:59 - Award - UK6 - Contract Award Notice - https://www.find-tender.service.gov.uk/Notice/015976-2026
- 16 Feb 2026 at 15:13 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/013933-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/015976-2026
  23rd February 2026 - Contract award notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/013933-2026
  16th February 2026 - Transparency notice on Find a Tender

## Notice URLs

- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-065523. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-065523.json.